Target Healthcare REIT (LON:THRL – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 103.61 and traded as high as GBX 108. Target Healthcare REIT shares last traded at GBX 107.40, with a volume of 13,346,642 shares traded.
Analysts Set New Price Targets
Separately, Jefferies Financial Group restated a “hold” rating and issued a GBX 101 price target on shares of Target Healthcare REIT in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of GBX 101.
Get Our Latest Research Report on THRL
Target Healthcare REIT Trading Down 0.4%
Target Healthcare REIT (LON:THRL – Get Free Report) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 3.38 earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. As a group, analysts predict that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Recommended Stories
- Five stocks we like better than Target Healthcare REIT
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
